Insights, Clinical Trials, and Advancements in Pathology Automation

April 19, 2024

By Michael Dugan, M.D. Nearly all automotive and aviation assembly uses similar processes, however in laboratories, particularly anatomic pathology which is less automated, we may think of the workflow process in a linear fashion. Such ideas are quickly becoming outdated. Today a multi-faceted, multi-component process of assembling a final report is possible.

March 15, 2024

FormaPath is excited to head to Chicago for the American Association of Pathologists' Assistants Spring Meeting.

March 14, 2024

We are very excited to return to USCAP this year. We will be on the exhibit floor at Booth #208.

March 14, 2024

The main impact of automation that drives its development and adoption is consistency. Consistency is valuable in a Pathology lab because it delivers benefits across quality, timing, cost and reliability. However, the pursuit of consistency in the lab must be balanced with the inherent variety of specimens that the lab is tasked with analyzing. FormaPath is extremely mindful of figuring out which processes can be automated so that more time can be dedicated to more important and complex tasks.

April 19, 2024

By Michael Dugan M.D. For pathologists, realizing faster turnaround times and more reliable results with the help of AdiPress has the potential to improve cancer care by helping to deliver critical information on pathologic staging that will inform adjuvant care decisions for colon cancer patients.

March 14, 2024

FormaPath and Dr. John Tomaszewski, SUNY Distinguished Professor and Chair of Pathology and Anatomical Sciences at the Jacobs School of Medicine and Biomedical Sciences at UB, will use AdiPress to conduct comprehensive analyses of tissue specimens to identify and create lymph node-rich samples. This work will lead to the eventual creation of a digital lymph node database, which will allow FormaPath to explore computational methods—including AI—that identify and analyze lymph nodes with metastatic disease.